Scl-70 Ab ELISA Kit


Human Scl-70 Ab ELISA kit is designed for determining in-vitro quantitative concentrations of IgG auto-antibodies to Scl-70 antibody (anti Scl-70, Scl-70 Ab, anti-Scl 70 antibody, topoisomerase 1, topo-1, anti-topoisomerase 1) in human plasma and serum. This assay has a minimum analytical sensitivity limit of 1.0 U/ml.


Scl-70 (also called Topoisomerase 1) is a nucleolar and nuclear enzyme which is regarded as being specific for systemic sclerosis (scleroderma) and it can be found in over 60% of patients possessing this connective tissue disease. Scleroderma has been associated with a number of autoantibodies, each of which can be helpful in diagnosing the affected patients and in determining the prognosis. Anti-Scl-70 and anti-centromere antibodies (ACA) are particularly useful in distinguishing patients having systemic sclerosis (SSc), these antibodies are associated with more severe scleroderma disease.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Divisible Microplate: Consisting of 12 modules of 8 wells, highly purified Scl-70 antibodies bound to microwells.
  • Calibrators (A-F): Concentration 0-200 U/ml, made up from anti-Scl-70 in a serum/buffer matrix.
  • Controls Positive and Control Negative: Containing anti-Scl-70 antibodies.
  • Sample Buffer (5x).
  • Enzyme Conjugate: Contains anti-human IgG antibodies, HRP labelled.
  • TMB Substrate.
  • Stop Solution: Contains acid.
  • Wash Buffer (50x Concentrated).
  • Instruction Manual.
  • Certificate of Analysis.


The minimum detection sensitivity level of human anti-Scl 70 antibody (anti-Scl-70, Scl-70 Ab, topoisomerase 1, anti-topoisomerase 1, topo-1) IgG autoantibodies using current Scl-70 antibody ELISA kit was 1.0 U/ml. The dynamic range for this assay is 12.5 – 200.0 U/ml.


– Scl-70 Antibody (Anti-Scl 70 Ab): ELISA
– Expected Values: Cut-off 25 U/ml.
– Limit Of Detection (LOD): 1 U/ml.
– Measuring Range: 0 – 200 U/ml
– Interference: None.
– Results Interpretation: Negative: < 15 U/ml, Borderline 15-25 U/ml, Positive: ≥ 25 U/ml.
– Intra Assay: 3.2 – 4.0%
– Inter Assay: 2.3 – 2.8%
– Linearity: 97 – 104%
– Clinical Diagnosis: Sensitivity (76.0%), Specificity (99.0%), Overall agreement (94.4%).


  1. An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70. J Immunol Methods. (1985) 80 (2): 211-9. Geisler C. and Høier-Madsen M.
  2. Anti-Scl-70 (topo-I) antibodies in SLE: Myth or reality? Autoimmun Rev. (2010) 9 (11): 756-60. Review. Mahler M., et al.
  3. Development and comparative evaluation of immunoblot assays for detecting autoantibodies to Scl 70 and Jo 1 antigens in serum. Clin Chem. (1990) 36 (12): 2053-6. Fonong T., et al.
  4. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science. (1986) 231 (4739): 737-40. Shero J.H., et al.
  5. Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I. Chromosoma. (1986) 94 (2): 132-8. Guldner H.H., et al.
  6. Anti-scl-70. Autoimmunity. (2005) 38 (1): 65-72. Review. Basu D. and Reveille JD.


  • Full Name: Scl-70 Ab ELISA Kit
  • Reactivity: Human
  • Sample Type: Serum, Plasma
  • Sensitivity: 1.0 U/ml



Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford